Study the Role of Chfr in Tumorigenesis

研究 Chfr 在肿瘤发生中的作用

基本信息

  • 批准号:
    7626047
  • 负责人:
  • 金额:
    $ 8.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-07-01 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Chromosomal instability is a common feature of human cancers. Chromosomal instability allows the accumulation of multiple genetic alterations that ultimately leads to the development of cancer. Increasing evidence in the last decade suggest that mitotic checkpoint controls are essential for the maintenance of chromosomal stability. Chfr (checkpoint with FHA and ring finger domains) is a newly identified checkpoint protein involved in mitotic transitions. Studies of human primary tumors and tumor cell lines suggest that Chfr downregulation is associated with human cancer development. However, it remains to be determined whether Chfr downregulation directly contributes to tumorigenesis. We recently generated Chfr knockout mice. Using these mice, we have demonstrated that Chfr-deficient mice have an increased incidence of spontaneous and carcinogen-induced tumors, suggesting that loss or downregulation of Chfr expression contributes to tumorigenesis. Here, we propose to study mechanistically how Chfr controls mitotic progression and suppress tumor formation. Chfr contains a RING domain and has E3 ubiquitin ligase activity in vitro. We have shown that one of the physiological substrates of Chfr is a key mitotic kinase Aurora-A. In Specific Aim 1, we will determine the structure of Chfr/Aurora A complex and study at molecular level how Chfr interacts with and regulates Aurora A. In Specific Aim 2, we will explore whether Aurora A overexpression and/or p53 mutation are critical for tumor development in the absence of Chfr. These studies will reveal the mechanisms by which Chfr deficiency promotes tumorigenesis. We and others have shown that Chfr is frequently downregulated in colorectal cancers, suggesting that Chfr deficiency may contribute to colorectal cancer development in humans. This possibility will be explored in Specific Aim 3. In conclusion, studies outlined here will elucidate the precise molecular role of Chfr in the control of mitotic transition, and provide insights into the function of this newly defined early mitotic checkpoint in the maintenance of genomic stability and cancer prevention.
描述(由申请人提供):染色体不稳定性是人类癌症的常见特征。染色体的不稳定性允许多种遗传改变的积累,最终导致癌症的发展。在过去的十年中,越来越多的证据表明,有丝分裂检查点控制是必不可少的染色体稳定性的维护。Chfr(checkpoint with FHA and ring finger domains)是一种新发现的参与有丝分裂转换的检查点蛋白。对人类原发性肿瘤和肿瘤细胞系的研究表明,Chfr下调与人类癌症的发展有关。然而,它仍然有待确定是否Chfr下调直接有助于肿瘤的发生。我们最近产生了Chfr敲除小鼠。使用这些小鼠,我们已经证明,Chfr-缺陷小鼠有自发性和致癌物质诱导的肿瘤的发病率增加,这表明Chfr表达的损失或下调有助于肿瘤的发生。在这里,我们建议研究机制如何Chfr控制有丝分裂的进展和抑制肿瘤的形成。Chfr含有一个RING结构域,在体外具有E3泛素连接酶活性。我们已经表明,Chfr的生理底物之一是一个关键的有丝分裂激酶Aurora-A。在具体目标1中,我们将确定Chfr/Aurora A复合物的结构,并在分子水平上研究Chfr如何与Aurora A相互作用并调节Aurora A。在特定目标2中,我们将探讨在缺乏Chfr的情况下,Aurora A过表达和/或p53突变是否对肿瘤发展至关重要。这些研究将揭示Chfr缺陷促进肿瘤发生的机制。我们和其他人已经表明,Chfr在结直肠癌中经常下调,这表明Chfr缺乏可能有助于人类结直肠癌的发展。具体目标3将探讨这种可能性。总之,本文概述的研究将阐明Chfr在控制有丝分裂转变中的精确分子作用,并提供对这种新定义的早期有丝分裂检查点在维持基因组稳定性和癌症预防中的功能的见解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Junjie Chen其他文献

Junjie Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Junjie Chen', 18)}}的其他基金

Deciphering pathways involved in topoisomerase II turnover
破译拓扑异构酶 II 周转涉及的途径
  • 批准号:
    10552113
  • 财政年份:
    2023
  • 资助金额:
    $ 8.87万
  • 项目类别:
Elucidating mechanisms underlying replication checkpoint control
阐明复制检查点控制的底层机制
  • 批准号:
    10620981
  • 财政年份:
    2023
  • 资助金额:
    $ 8.87万
  • 项目类别:
Exploring DNA damage response pathways as targets for cancer therapy
探索 DNA 损伤反应途径作为癌症治疗的目标
  • 批准号:
    10515484
  • 财政年份:
    2022
  • 资助金额:
    $ 8.87万
  • 项目类别:
Novel regulations of DNA damage repair
DNA损伤修复的新调控
  • 批准号:
    9883637
  • 财政年份:
    2017
  • 资助金额:
    $ 8.87万
  • 项目类别:
Novel regulations of DNA damage repair
DNA损伤修复的新调控
  • 批准号:
    10087898
  • 财政年份:
    2017
  • 资助金额:
    $ 8.87万
  • 项目类别:
Novel regulations of DNA damage repair
DNA损伤修复的新调控
  • 批准号:
    9326453
  • 财政年份:
    2017
  • 资助金额:
    $ 8.87万
  • 项目类别:
Define redundant functions of H2AX and NBS1 in DNA repair
定义DNA修复中H2AX和NBS1的冗余功能
  • 批准号:
    10311996
  • 财政年份:
    2017
  • 资助金额:
    $ 8.87万
  • 项目类别:
Project 4: Coordinating Nucleolytic Pathways During Crosslink Repair
项目 4:在交联修复过程中协调溶核途径
  • 批准号:
    9148677
  • 财政年份:
    2017
  • 资助金额:
    $ 8.87万
  • 项目类别:
Define redundant functions of H2AX and NBS1 in DNA repair
定义DNA修复中H2AX和NBS1的冗余功能
  • 批准号:
    9206732
  • 财政年份:
    2017
  • 资助金额:
    $ 8.87万
  • 项目类别:
Define redundant functions of H2AX and NBS1 in DNA repair
定义DNA修复中H2AX和NBS1的冗余功能
  • 批准号:
    10053713
  • 财政年份:
    2017
  • 资助金额:
    $ 8.87万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 8.87万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 8.87万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.87万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 8.87万
  • 项目类别:
    Discovery Early Career Researcher Award
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 8.87万
  • 项目类别:
    Continuing Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 8.87万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 8.87万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Analysis of thermoregulatory mechanisms by the CNS using model animals of female-dominant infectious hypothermia
使用雌性传染性低体温模型动物分析中枢神经系统的体温调节机制
  • 批准号:
    23KK0126
  • 财政年份:
    2023
  • 资助金额:
    $ 8.87万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 8.87万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 8.87万
  • 项目类别:
    Training Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了